HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuka Kobayashi Selected Research

Bendamustine Hydrochloride

8/2023Risk of a second cancer and infection in patients with indolent B-cell lymphoma exposed to first-line bendamustine plus rituximab: A retrospective analysis of an administrative claims database.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuka Kobayashi Research Topics

Disease

21Neoplasms (Cancer)
08/2023 - 01/2002
20Neuralgia (Stump Neuralgia)
07/2015 - 09/2008
15Hyperalgesia
05/2015 - 09/2008
10Pain (Aches)
01/2021 - 04/2007
8Inflammation (Inflammations)
01/2019 - 01/2013
7Neuroinflammatory Diseases
01/2014 - 01/2009
6Colorectal Neoplasms (Colorectal Cancer)
08/2023 - 09/2010
6Infections
08/2023 - 01/2006
5Hemorrhage
04/2016 - 05/2012
4Macular Degeneration (Age-Related Maculopathy)
11/2021 - 11/2017
4Stomach Neoplasms (Stomach Cancer)
10/2018 - 05/2010
4Peripheral Nerve Injuries
05/2012 - 11/2008
4Neoplasm Metastasis (Metastasis)
11/2010 - 12/2000
3Wounds and Injuries (Trauma)
01/2022 - 07/2014
3Fibrosis (Cirrhosis)
01/2021 - 01/2019
3Pancreatic Neoplasms (Pancreatic Cancer)
06/2019 - 06/2015
2Cardiovascular Diseases (Cardiovascular Disease)
02/2023 - 01/2022
2Open Fractures (Compound Fracture)
06/2022 - 07/2020
2Colonic Neoplasms (Colon Cancer)
01/2022 - 11/2020
2Acute Kidney Injury (Acute Renal Failure)
12/2021 - 10/2021
2Pathologic Constriction (Stenosis)
11/2021 - 11/2014
2Macular Edema
09/2021 - 11/2017
2Retinal Diseases
01/2021 - 01/2019
2Edema (Dropsy)
11/2020 - 11/2013
2Diabetes Mellitus
06/2020 - 01/2007
2Leukemia
04/2020 - 01/2009
2Uveitis
01/2020 - 01/2019
2Burning Mouth Syndrome (Syndrome, Burning Mouth)
07/2017 - 07/2015
2Liver Cirrhosis (Hepatic Cirrhosis)
04/2016 - 01/2016
2Liver Neoplasms (Liver Cancer)
02/2016 - 01/2014
2Polyps
11/2015 - 02/2012
2Hepatocellular Carcinoma (Hepatoma)
01/2013 - 10/2012
2Lymphoma (Lymphomas)
01/2009 - 01/2002
1Paralysis (Palsy)
10/2023
1Lymphopenia (Lymphocytopenia)
08/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2023
1Proteinuria
08/2023
1Second Primary Neoplasms (Neoplasms, Second)
08/2023

Drug/Important Bio-Agent (IBA)

10Capsules (Microcapsules)IBA
09/2017 - 02/2012
7CytokinesIBA
01/2019 - 11/2008
6Biomarkers (Surrogate Marker)IBA
06/2019 - 10/2012
6LigandsIBA
07/2015 - 03/2012
5ChemokinesIBA
08/2014 - 10/2010
5Vincristine (Oncovin)FDA LinkGeneric
02/2014 - 09/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 04/2014
4LectinsIBA
06/2019 - 06/2015
4Neutralizing AntibodiesIBA
05/2015 - 09/2008
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2015 - 11/2008
4CC ChemokinesIBA
08/2014 - 10/2010
4Interleukin-6 (Interleukin 6)IBA
01/2009 - 09/2008
3Retinal Pigments (Pigments, Visual)IBA
01/2021 - 01/2019
3Anti-Bacterial Agents (Antibiotics)IBA
07/2020 - 11/2013
3HaptoglobinsIBA
06/2019 - 03/2016
3OligosaccharidesIBA
08/2016 - 10/2012
3EnzymesIBA
06/2016 - 01/2015
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2016 - 07/2014
3Opioid Analgesics (Opioids)IBA
06/2015 - 07/2009
2RamucirumabIBA
08/2023 - 01/2020
2Rituximab (Mabthera)FDA Link
08/2023 - 02/2014
2Tobacco Smoke Pollution (Passive Smoking)IBA
02/2023 - 01/2022
2AC133 AntigenIBA
01/2023 - 11/2021
2Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
12/2021 - 10/2021
2VancomycinFDA LinkGeneric
12/2021 - 10/2021
2Bisoprolol (Concor)FDA LinkGeneric
01/2021 - 01/2012
2Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2019
2myocardinIBA
01/2021 - 01/2019
2Therapeutic UsesIBA
04/2020 - 04/2015
2Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2015
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2020 - 01/2019
2Retinaldehyde (Retinal)IBA
01/2019 - 11/2017
2AntibodiesIBA
12/2018 - 10/2018
2Cetuximab (Erbitux)FDA Link
10/2018 - 01/2018
2Leucovorin (Folinic Acid)FDA Link
10/2018 - 07/2012
2Panitumumab (Vectibix)FDA Link
10/2018 - 01/2018
2Fluorouracil (Carac)FDA LinkGeneric
10/2018 - 07/2012
2Docetaxel (Taxotere)FDA Link
10/2018 - 05/2006
2CXCR ReceptorsIBA
01/2018 - 04/2014
2Duloxetine Hydrochloride (Cymbalta)FDA Link
07/2017 - 07/2015
2Hemoglobins (Hemoglobin)IBA
05/2017 - 01/2015
2Mitogen-Activated Protein KinasesIBA
11/2016 - 10/2009
2Proteins (Proteins, Gene)FDA Link
06/2016 - 05/2010
2GlucocorticoidsIBA
01/2016 - 05/2015
2Analgesics (Analgesic Drugs)IBA
06/2015 - 01/2013
2salicylhydroxamic acid (SHAM)IBA
11/2014 - 05/2010
2Fetal Proteins (Fetoprotein)IBA
01/2014 - 10/2012
2Histones (Histone)IBA
12/2013 - 03/2012
2NicotineFDA Link
12/2012 - 05/2010
1Bevacizumab (Avastin)FDA Link
08/2023
1Bendamustine HydrochlorideFDA Link
08/2023

Therapy/Procedure

15Therapeutics
08/2023 - 05/2006
11Drug Therapy (Chemotherapy)
08/2023 - 07/2009
6Ligation
12/2013 - 08/2009
3Gastrectomy
10/2011 - 12/2000
2Free Tissue Flaps
06/2022 - 01/2022
2Vitrectomy
01/2022 - 11/2017
2Light Coagulation
01/2021 - 01/2019
2Osteotomy
12/2017 - 01/2009
2Splints (Splint)
12/2015 - 04/2010
2Adjuvant Chemotherapy
11/2010 - 09/2010
1Sutures (Suture)
10/2023